Chronic treatment with phenobarbital decreases the expression of rat liver EGF and insulin receptors

This publication has 20 references indexed in Scilit:

• Tumour-promoting phorbol esters increase basal and inhibit insulin-stimulated lipogenesis in rat adipocytes without decreasing insulin binding
  Biochemical Journal, 1985
• Effects of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on metabolism of the epidermal growth factor receptor in normal human fibroblasts.
  Molecular and Cellular Biology, 1984
• Phorbol ester-induced threonine phosphorylation of the human epidermal growth factor receptor occurs within the EGF binding domain
  Biochemical and Biophysical Research Communications, 1984
• Effects of the Hepatocarcinogen 2-Acetylaminofluorene on Insulin Binding to Microsomal and Golgi Fractions of Rat Liver Cells2
  JNCI Journal of the National Cancer Institute, 1984
• Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide
  Carcinogenesis: Integrative Cancer Research, 1984
• Multistage carcinogenesis involves multiple genes and multiple mechanisms
  Journal of Cellular Physiology, 1984
• Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system
  Nature, 1982
• Studies on the mechanism by which a tumor promoter inhibits binding of epidermal growth factor to cellular receptors
  Carcinogenesis: Integrative Cancer Research, 1980
• Tumor-Promoting Phorbol Esters Inhibit Binding of Epidermal Growth Factor to Cellular Receptors
  Science, 1978